North America Legal Chronicle. January 18, 2023

Belharra Therapeutics’ Multi-year Collaboration with Genentech

By Martina Bellini

Fenwick represented Belharra Therapeutics on the deal. Belharra Therapeutics, a privately held drug discovery company with a novel photoaffinity-based, non-covalent chemoproteomics platform, announced its multi-year collaboration with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here